of Boston Scientific’s commercially available Vercise DBS system in the treatment of
Additionally, the utilization of Guide XT (GXT) System when used as a planning tool for the
programming of patients with the Boston Scientific’s Vercise DBS Systems is also evaluated.
– Meets criteria established in locally applicable Vercise System Direction for Use
– At least 18 years old
Key Exclusion Criteria:
– Meets any contraindication in the Vercise System locally applicable Directions for Use
Subjects with significant cognitive or psychiatric impairment may be excluded in the
evaluation of GXT.
- Boston Scientific Clinical Research Toll-Free Number, Valencia, California, United States, 91355